Ravi Biochemicals (India) Profile
Key Indicators
- Authorised Capital ₹ 1.60 M
as on 15-12-2024
- Paid Up Capital ₹ 1.60 M
as on 15-12-2024
- Company Age 19 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 49.21%
(FY 2017)
- Profit 132.26%
(FY 2017)
- Ebitda 8.08%
(FY 2017)
- Net Worth 0.34%
(FY 2017)
- Total Assets 0.04%
(FY 2017)
About Ravi Biochemicals (India)
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.60 M and a paid-up capital of Rs 1.60 M, as per Ministry of Corporate Affairs (MCA) records.
Ashish Doshi, Hardik Doshi, and Kalpanaben Doshi serve as directors at the Company.
- CIN/LLPIN
U24200MH2005PTC157324
- Company No.
157324
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ravi Biochemicals (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Doshi  | Director | 02-Feb-2010 | Current |
| Hardik Doshi | Director | 02-Feb-2010 | Current |
| Kalpanaben Doshi | Director | 23-Mar-2015 | Current |
Financial Performance and Corporate Structure Insights of Ravi Biochemicals (India).
Ravi Biochemicals (India) Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 49.21% increase. The company also saw a substantial improvement in profitability, with a 132.26% increase in profit. The company's net worth moved up by a moderate rise of 0.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ravi Biochemicals (India)?
In 2017, Ravi Biochemicals (India) had a promoter holding of 25.00% and a public holding of 75.00%. The company had 4 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Orange City Steel Industries Private LimitedActive 26 years 5 monthsAshish Doshi and Hardik Doshi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ravi Biochemicals (India)?
Unlock and access historical data on people associated with Ravi Biochemicals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ravi Biochemicals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ravi Biochemicals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
